BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 805659)

  • 1. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
    van Nagell JR; Pletsch QA; Goldenberg DM
    Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the carcinoembryonic antigen activity associated with cyst fluids of mucinous ovarian cystadenocarcinoma.
    Yamashita K; Aitio ML; Dawson JR
    Cancer Res; 1979 May; 39(5):1760-5. PubMed ID: 85489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms.
    Harłozińska A; Bar JK; Gawlikowski W; Richter R; Cisło M
    Ann Chir Gynaecol; 1991; 80(4):368-75. PubMed ID: 1667567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors.
    Tohya T; Iwamasa T; Maeyama M
    Gynecol Oncol; 1986 Mar; 23(3):291-303. PubMed ID: 3514390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen in human ovarian neoplasms.
    Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
    Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors].
    Kunze M; Büttner HH; Strache RR; Voss P; Briese V; Schrodt U
    Zentralbl Gynakol; 1988; 110(16):1006-12. PubMed ID: 3188713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma carcinoembryonic antigen levels in ovarian cancer patients: a chart review and survey of published data.
    Stall KE; Martin EW
    J Reprod Med; 1981 Feb; 26(2):73-9. PubMed ID: 7012337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic biliary cystadenoma: role of cyst fluid analysis and surgical management in the laparoscopic era.
    Koffron A; Rao S; Ferrario M; Abecassis M
    Surgery; 2004 Oct; 136(4):926-36. PubMed ID: 15467680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
    JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor and serum CEA content in gynecologic neoplasms.
    Kula J; Richter R; Gawlikowski W; Harłozińska A
    Neoplasma; 1984; 31(1):89-93. PubMed ID: 6322027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated antigen for cystadenocarcinomas of the ovary.
    Bhattacharya M; Barlow JJ
    Natl Cancer Inst Monogr; 1975 Oct; 42():25-32. PubMed ID: 825781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucinous cystic neoplasm of the pancreas with high carcinoembryonic antigen.
    Yu HC; Shetty J
    Arch Pathol Lab Med; 1985 Apr; 109(4):375-7. PubMed ID: 3885900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms.
    Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M
    Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
    de Bruijn HW; ten Hoor KA; Boonstra H; Marrink J; Krans M; Aalders JG
    Tumour Biol; 1993; 14(2):105-15. PubMed ID: 8392219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
    Tatsuta M; Iishi H; Ichii M; Noguchi S; Yamamoto R; Yamamura H; Okuda S
    Cancer; 1986 May; 57(9):1836-9. PubMed ID: 2420441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
    Ayhan A; Guven S; Guven ES; Kucukali T
    Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma.
    Wu H; Yan LN; Cheng NS; Zhang YG; Ker CG
    Hepatogastroenterology; 2007; 54(79):1915-8. PubMed ID: 18251127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor associated antigen in ovarian carcinoma.
    Negishi Y; Mutai Y; Akiya K; Fujiwara Y; Singh G
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):126-32. PubMed ID: 6199439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.